1. Orbital mucosa-associated lymphoid tissue (MALT) lymphoma as the initial presentation in patients with hepatitis C virus infection.
- Author
-
Lloreda-Martin L, Berrocal-Cuadrado A, Torres Nieto MA, and Galindo-Ferreiro A
- Subjects
- Male, Humans, Middle Aged, Hepacivirus, Lymphoid Tissue, Mucous Membrane, Lymphoma, B-Cell, Marginal Zone complications, Lymphoma, B-Cell, Marginal Zone drug therapy, Hepatitis C complications, Hepatitis C drug therapy
- Abstract
Hepatitis C virus infection may be implicated in 12.7% of ocular adnexal marginal zone lymphomas. We present the first case of an orbital-systemic mucosa-associated lymphoid tissue lymphoma that responded to hepatitis C virus medical treatment. A 62-year-old male with a right-sided orbital mass was diagnosed with stage IIA orbital marginal zone lymphoma in addition to hepatitis C virus infection based on clinical, imaging, laboratory, and histological examinations. The systemic and orbital responses were achieved 1 year after undergoing hepatitis C virus treatment with glecaprevir/pibrentasvir. The association between the hepatitis C virus infection and orbital-systemic mucosa-associated lymphoid tissue lymphoma is relevant. Accordingly, patients with orbital mucosa-associated lymphoid tissue lymphoma should be assessed for hepatitis C virus seroreactivity for therapeutic and prognostic purposes.
- Published
- 2024
- Full Text
- View/download PDF